| abstract |
The present invention discloses a stable pharmaceutical formulation of a fusion protein, wherein the formulation contains buffer, sugar alcohol/polyol, amino acid and surfactant, and wherein the formulation is devoid of sucrose. Additionally, the formulation may also be devoid of a salt. The disclosed fusion protein formulations are liquid formulations that are also suitable for lyophilization. |